Abstract
1. The effects of intracerebroventricular (i.c.v.) pretreatment with selective NK1 ((+/-)-CP 96,345), NK2a (MEN 10,207; MEN 10,376) and NK2b (R 396) tachykinin receptor antagonists on the cardiovascular and behavioural responses to i.c.v. substance P (SP) and neurokinin A (NKA) were studied in conscious rats. 2. SP and NKA (25 pmol) induced mean arterial blood pressure and heart rate increases of the same magnitude and duration. The cardiovascular responses to both peptides were accompanied by excessive face washing, sniffing, grooming and wet dog shakes. 3. The cardiovascular responses to SP but not to NKA were attenuated by pretreatment with a NK1 receptor antagonist, (+/-)-CP 96,345. Of the behavioural responses, only face washing was significantly inhibited. 4. The cardiovascular and behavioural effects of NKA but not of SP were significantly attenuated by pretreatment with the selective NK2b receptor antagonist, R 396. 5. The selective NK2a receptor antagonists, MEN 10,207 and MEN 10,376, did not affect the cardiovascular and behavioural responses to either SP or NKA. 6. These results suggest, firstly, that the cardiovascular and behavioural effects of i.c.v. SP are mediated by NK1 receptors; secondly, that NKA injected i.c.v. does not interact with NK1 receptors but with another type of tachykinin receptor which may belong to the NK2b subclass. These findings provide pharmacological evidence for the existence of functionally active NK2 receptors in the rat brain.
Full text
PDF





Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Arai H., Emson P. C. Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system. Brain Res. 1986 Dec 10;399(2):240–249. doi: 10.1016/0006-8993(86)91514-3. [DOI] [PubMed] [Google Scholar]
- Bergström L., Torrens Y., Saffroy M., Beaujouan J. C., Lavielle S., Chassaing G., Morgat J. L., Glowinski J., Marquet A. [3H]neurokinin B and 125I-Bolton Hunter eledoisin label identical tachykinin binding sites in the rat brain. J Neurochem. 1987 Jan;48(1):125–133. doi: 10.1111/j.1471-4159.1987.tb13136.x. [DOI] [PubMed] [Google Scholar]
- Buck S. H., Harbeson S. L., Hassmann C. F., 3rd, Shatzer S. A., Rouissi N., Nantel F., van Giersbergen P. L. [Leu9 psi(CH2NH)Leu10]-neurokinin A (4-10) (MDL 28,564) distinguishes tissue tachykinin peptide NK2 receptors. Life Sci. 1990;47(10):PL37–PL41. doi: 10.1016/0024-3205(90)90605-q. [DOI] [PubMed] [Google Scholar]
- Buck S. H., Helke C. J., Burcher E., Shults C. W., O'Donohue T. L. Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous system. Peptides. 1986 Nov-Dec;7(6):1109–1120. doi: 10.1016/0196-9781(86)90141-5. [DOI] [PubMed] [Google Scholar]
- Couture R., Laneuville O., Guimond C., Drapeau G., Regoli D. Characterization of the peripheral action of neurokinins and neurokinin receptor selective agonists on the rat cardiovascular system. Naunyn Schmiedebergs Arch Pharmacol. 1989 Nov;340(5):547–557. doi: 10.1007/BF00260610. [DOI] [PubMed] [Google Scholar]
- Dam T. V., Escher E., Quirion R. Evidence for the existence of three classes of neurokinin receptors in brain. Differential ontogeny of neurokinin-1, neurokinin-2 and neurokinin-3 binding sites in rat cerebral cortex. Brain Res. 1988 Jun 21;453(1-2):372–376. doi: 10.1016/0006-8993(88)90181-3. [DOI] [PubMed] [Google Scholar]
- Dam T. V., Takeda Y., Krause J. E., Escher E., Quirion R. gamma-Preprotachykinin-(72-92)-peptide amide: an endogenous preprotachykinin I gene-derived peptide that preferentially binds to neurokinin-2 receptors. Proc Natl Acad Sci U S A. 1990 Jan;87(1):246–250. doi: 10.1073/pnas.87.1.246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dietl M. M., Palacios J. M. Phylogeny of tachykinin receptor localization in the vertebrate central nervous system: apparent absence of neurokinin-2 and neurokinin-3 binding sites in the human brain. Brain Res. 1991 Jan 25;539(2):211–222. doi: 10.1016/0006-8993(91)91623-9. [DOI] [PubMed] [Google Scholar]
- Elliott P. J., Iversen S. D. Behavioural effects of tachykinins and related peptides. Brain Res. 1986 Aug 27;381(1):68–76. doi: 10.1016/0006-8993(86)90691-8. [DOI] [PubMed] [Google Scholar]
- Gispen W. H., Wiegant V. M., Greven H. M., de Wied D. The induction of excessive grooming in the rat by intraventricular application of peptides derived from ACTH: structure-activity studies. Life Sci. 1975 Aug 15;17(4):645–652. doi: 10.1016/0024-3205(75)90103-4. [DOI] [PubMed] [Google Scholar]
- Gitter B. D., Waters D. C., Bruns R. F., Mason N. R., Nixon J. A., Howbert J. J. Species differences in affinities of non-peptide antagonists for substance P receptors. Eur J Pharmacol. 1991 May 17;197(2-3):237–238. doi: 10.1016/0014-2999(91)90532-u. [DOI] [PubMed] [Google Scholar]
- Hasséssian H., Couture R. Cardiovascular responses induced by intrathecal substance P in the conscious freely moving rat. J Cardiovasc Pharmacol. 1989 Apr;13(4):594–602. [PubMed] [Google Scholar]
- Hasséssian H., Couture R., de Champlain J. Sympathoadrenal mechanisms underlying cardiovascular responses to intrathecal substance P in conscious rats. J Cardiovasc Pharmacol. 1990 May;15(5):736–744. doi: 10.1097/00005344-199005000-00008. [DOI] [PubMed] [Google Scholar]
- Hasséssian H., Drapeau G., Couture R. Spinal action of neurokinins producing cardiovascular responses in the conscious freely moving rat: evidence for a NK-1 receptor mechanism. Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):649–654. doi: 10.1007/BF00165629. [DOI] [PubMed] [Google Scholar]
- Itoi K., Jost N., Badoer E., Tschöpe C., Culman J., Unger T. Localization of the substance P-induced cardiovascular responses in the rat hypothalamus. Brain Res. 1991 Aug 30;558(1):123–126. doi: 10.1016/0006-8993(91)90727-d. [DOI] [PubMed] [Google Scholar]
- Maggi C. A., Giuliani S., Ballati L., Lecci A., Manzini S., Patacchini R., Renzetti A. R., Rovero P., Quartara L., Giachetti A. In vivo evidence for tachykininergic transmission using a new NK-2 receptor-selective antagonist, MEN 10,376. J Pharmacol Exp Ther. 1991 Jun;257(3):1172–1178. [PubMed] [Google Scholar]
- Maggi C. A., Patacchini R., Giuliani S., Rovero P., Dion S., Regoli D., Giachetti A., Meli A. Competitive antagonists discriminate between NK2 tachykinin receptor subtypes. Br J Pharmacol. 1990 Jul;100(3):589–592. doi: 10.1111/j.1476-5381.1990.tb15851.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mantyh P. W., Gates T., Mantyh C. R., Maggio J. E. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J Neurosci. 1989 Jan;9(1):258–279. doi: 10.1523/JNEUROSCI.09-01-00258.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McLean S., Ganong A. H., Seeger T. F., Bryce D. K., Pratt K. G., Reynolds L. S., Siok C. J., Lowe J. A., 3rd, Heym J. Activity and distribution of binding sites in brain of a nonpeptide substance P (NK1) receptor antagonist. Science. 1991 Jan 25;251(4992):437–439. doi: 10.1126/science.1703324. [DOI] [PubMed] [Google Scholar]
- Minamino N., Masuda H., Kangawa K., Matsuo H. Regional distribution of neuromedin K and neuromedin L in rat brain and spinal cord. Biochem Biophys Res Commun. 1984 Nov 14;124(3):731–738. doi: 10.1016/0006-291x(84)91019-2. [DOI] [PubMed] [Google Scholar]
- Nakanishi S. Mammalian tachykinin receptors. Annu Rev Neurosci. 1991;14:123–136. doi: 10.1146/annurev.ne.14.030191.001011. [DOI] [PubMed] [Google Scholar]
- Nawa H., Hirose T., Takashima H., Inayama S., Nakanishi S. Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor. Nature. 1983 Nov 3;306(5938):32–36. doi: 10.1038/306032a0. [DOI] [PubMed] [Google Scholar]
- Nawa H., Kotani H., Nakanishi S. Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing. Nature. 1984 Dec 20;312(5996):729–734. doi: 10.1038/312729a0. [DOI] [PubMed] [Google Scholar]
- Patacchini R., Astolfi M., Quartara L., Rovero P., Giachetti A., Maggi C. A. Further evidence for the existence of NK2 tachykinin receptor subtypes. Br J Pharmacol. 1991 Sep;104(1):91–96. doi: 10.1111/j.1476-5381.1991.tb12390.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Quirion R., Dam T. V., Guard S. Selective neurokinin receptor radioligands. Ann N Y Acad Sci. 1991;632:137–144. doi: 10.1111/j.1749-6632.1991.tb33102.x. [DOI] [PubMed] [Google Scholar]
- Regoli D., Drapeau G., Dion S., Couture R. New selective agonists for neurokinin receptors: pharmacological tools for receptor characterization. Trends Pharmacol Sci. 1988 Aug;9(8):290–295. doi: 10.1016/0165-6147(88)90013-2. [DOI] [PubMed] [Google Scholar]
- Saffroy M., Beaujouan J. C., Torrens Y., Besseyre J., Bergström L., Glowinski J. Localization of tachykinin binding sites (NK1, NK2, NK3 ligands) in the rat brain. Peptides. 1988 Mar-Apr;9(2):227–241. doi: 10.1016/0196-9781(88)90255-0. [DOI] [PubMed] [Google Scholar]
- Snider R. M., Constantine J. W., Lowe J. A., 3rd, Longo K. P., Lebel W. S., Woody H. A., Drozda S. E., Desai M. C., Vinick F. J., Spencer R. W. A potent nonpeptide antagonist of the substance P (NK1) receptor. Science. 1991 Jan 25;251(4992):435–437. doi: 10.1126/science.1703323. [DOI] [PubMed] [Google Scholar]
- Snider R. M., Longo K. P., Drozda S. E., Lowe J. A., 3rd, Leeman S. E. Effect of CP-96,345, a nonpeptide substance P receptor antagonist, on salivation in rats. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10042–10044. doi: 10.1073/pnas.88.22.10042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Stoessl A. J., Dourish C. T., Iversen S. D. The NK-3 tachykinin receptor agonist senktide elicits 5-HT-mediated behaviour following central or peripheral administration in mice and rats. Br J Pharmacol. 1988 Jun;94(2):285–287. doi: 10.1111/j.1476-5381.1988.tb11527.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Takano Y., Nagashima A., Hagio T., Tateishi K., Kamiya H. Role of central tachykinin peptides in cardiovascular regulation in rats. Brain Res. 1990 Oct 1;528(2):231–237. doi: 10.1016/0006-8993(90)91662-z. [DOI] [PubMed] [Google Scholar]
- Unger T., Becker H., Petty M., Demmert G., Schneider B., Ganten D., Lang R. E. Differential effects of central angiotensin II and substance P on sympathetic nerve activity in conscious rats. Implications for cardiovascular adaptation to behavioral responses. Circ Res. 1985 Apr;56(4):563–575. doi: 10.1161/01.res.56.4.563. [DOI] [PubMed] [Google Scholar]
- Unger T., Carolus S., Demmert G., Ganten D., Lang R. E., Maser-Gluth C., Steinberg H., Veelken R. Substance P induces a cardiovascular defense reaction in the rat: pharmacological characterization. Circ Res. 1988 Oct;63(4):812–820. doi: 10.1161/01.res.63.4.812. [DOI] [PubMed] [Google Scholar]
- van Giersbergen P. L., Shatzer S. A., Henderson A. K., Lai J., Nakanishi S., Yamamura H. I., Buck S. H. Characterization of a tachykinin peptide NK2 receptor transfected into murine fibroblast B82 cells. Proc Natl Acad Sci U S A. 1991 Mar 1;88(5):1661–1665. doi: 10.1073/pnas.88.5.1661. [DOI] [PMC free article] [PubMed] [Google Scholar]